RESEARCH DOSSIER
Trauma- and Stressor-Related Disorders
Abstract. Trauma- and stressor-related disorders are clinical syndromes for which identifiable stressful experiences form part of the diagnostic formulation. This critical narrative research monograph examines the historical development of trauma nosology; DSM-5-TR and ICD-11 diagnostic architectures; posttraumatic stress disorder (PTSD), complex PTSD, acute stress disorder and reactions, adjustment disorder, prolonged grief disorder, reactive attachment disorder, and disinhibited social engagement disorder; psychological learning, memory, cognitive, relational, developmental, and biological mechanisms; psychometric assessment; epidemiological heterogeneity; cultural and social contexts; interventions, and 2025–2026 advances in treatment comparisons and psychometric construct validity. The evidence synthesis integrates foundational experimental and prospective studies, psychometric validation, randomized clinical trials, clinical guidance, and independent meta-analyses. Major conclusions concern the separation of exposure from disorder, differences in diagnosis-specific evidence strength, the limitations of symptom-only and biomarker explanations, the documented effectiveness of several trauma-focused PTSD psychotherapies, and unresolved questions regarding complex PTSD, cultural applicability, long-term outcomes, and access to care. The work is a critical narrative synthesis, not an original experiment, systematic review, meta-analysis, clinical guideline, or independently peer-reviewed assessment.
Keywords: trauma- and stressor-related disorders; posttraumatic stress disorder; PTSD; complex PTSD; CPTSD; DSM-5-TR; ICD-11; acute stress disorder; adjustment disorder; prolonged grief disorder; reactive attachment disorder; disinhibited social engagement disorder; trauma-focused cognitive behavioral therapy; prolonged exposure; cognitive processing therapy; EMDR; International Trauma Questionnaire; CAPS-5; PCL-5; threat learning; trauma memory; stress-related psychopathology; clinical assessment
Introduction: Research Object, Scope, and Evidence Strategy
Trauma- and stressor-related disorders comprise clinically significant disturbances in which exposure to a specified event or adverse circumstance is integral to the diagnostic formulation. The defining event is heterogeneous across the grouping: exposure to actual or threatened death, serious injury, or sexual violence is central to posttraumatic stress disorder in DSM-5-TR, whereas marked adjustment problems may follow a broad range of identifiable life stressors, and prolonged grief follows bereavement. An exposure history establishes an essential context; it does not independently establish any disorder. Symptom organization, duration, impairment, developmental conditions, and alternative explanations determine whether the observed response meets a particular diagnostic threshold. This monograph investigates the psychological processes that connect stressful events to clinical trajectories and evaluates how different diagnostic systems assign those trajectories to categories. American Psychiatric Association (2022) World Health Organization (2024)
The scientific object is the relationship among stressor characteristics, appraisal, memory, emotion, defensive behavior, social adaptation, developmental context, and the organization of persistent symptoms. Five central questions organize the evidence: how classifications define stressor dependence; why similarly exposed individuals follow different courses; how trauma memory and avoidance processes contribute to persistence; how measurement instruments distinguish presentations; and which treatment effects follow from controlled research. The discussion includes acute stress responses, PTSD, ICD-11 complex PTSD, adjustment disorder, prolonged grief disorder, and childhood attachment-related disorders arising in severe caregiving adversity. It also addresses co-occurring depression, anxiety, substance misuse, dissociation, sleep disturbance, and functional disability where these features change assessment or outcomes. World Health Organization (2024) VA/DoD (2023)
The methodology is a critical narrative synthesis of original experimental and longitudinal studies, diagnostic classification documents, instrument development studies, randomized clinical trials, meta-analyses, and professional clinical guidelines. Evidence was selected for direct relevance to each research question, historical significance, diversity of design, and ability to test alternative accounts. No preregistered comprehensive search, formal dual-screened inclusion procedure, pooled effect-size reanalysis, or original clinical experiment was undertaken for this monograph. Therefore its conclusions are reasoned assessments of the cited literature, not estimates produced by a new systematic review. Where a result derives from a clinical guideline or a meta-analysis rather than a directly inspected original study, that provenance is made explicit. VA/DoD (2023) Bisson et al. (2013)
The grouping spans clinical psychology, developmental psychopathology, psychiatry, learning theory, cognitive neuroscience, and social epidemiology. A common conceptual mistake is to infer a diagnosis from severity of the event alone or to infer a fixed neural mechanism from a diagnostic label. The research field is organized through variable pathways: exposure, immediate response, symptom persistence, functioning, recovery, treatment, and long-term adaptation. A second mistake is to assume that a single explanatory model is equally powerful for severe threat, prolonged adversity, bereavement, and caregiver neglect. Models are evaluated in relation to the phenomena and populations they were designed to explain. Brewin et al. (2000) Koenen et al. (2017)
Historical Formation of Traumatic Stress and Clinical Classification
The historical vocabulary of trauma emerged through medical, neurological, and psychological debates concerning injury, accidents, warfare, and the relationship between distressing experiences and memory. Nineteenth-century descriptions of railway accidents and later wartime syndromes contributed observations of persistent fear, somatic disturbance, impaired functioning, and recurring recollection. Accounts of shell shock during the First World War revealed disagreement about physical injury, psychological causation, military discipline, and social recognition. The historical material matters because diagnostic interpretation is shaped by institutions, professional theory, and the definition of a legitimate precipitating event. Contemporary scientific judgments require evidence beyond the authority of those early descriptions. American Psychiatric Association (2022) World Health Organization (2024)
The inclusion of posttraumatic stress disorder in DSM-III in 1980 established an operational syndrome linked to an identifiable stressor and opened new research programs on combat exposure, assault, disaster, childhood trauma, and epidemiology. Diagnostic criteria subsequently changed through DSM-III-R, DSM-IV, and DSM-5. DSM-5 relocated PTSD and acute stress disorder from the anxiety disorders chapter into a dedicated trauma- and stressor-related grouping, acknowledging presentations involving fear, mood, cognition, anger, and dissociation. DSM-5-TR retained this framework while recognizing prolonged grief disorder as a distinct diagnosis. These historical developments produced changes in case definitions, so prevalence across eras cannot be interpreted as though criteria were constant. American Psychiatric Association (2022) VA/DoD (2023)
Independent international classification research culminated in the ICD-11 grouping of disorders specifically associated with stress. Its PTSD definition emphasizes re-experiencing the traumatic event in the present, avoidance, and a sustained sense of current threat. Complex PTSD adds disturbances in self-organization: affect regulation problems, persistently negative self-concept, and relationship disturbances. ICD-11 also includes prolonged grief disorder, adjustment disorder, reactive attachment disorder, and disinhibited social engagement disorder. Acute stress reaction is placed among factors influencing health status rather than classified as a mental disorder. This architecture represents a particular diagnostic balance between clinical utility and symptom parsimony; it is not a claim that categories correspond one-to-one with separable biological lesions. World Health Organization (2024) Cloitre et al. (2018)
The movement from early traumatic-neurosis descriptions to operational diagnosis enabled prospective designs, standardized assessment, randomized trials, and cross-national comparison. It also created new methodological obligations. When researchers report that PTSD rates differ among studies, they must identify whether the studies used lifetime or current prevalence, DSM or ICD criteria, self-report screening or structured clinical interviews, and which populations faced which exposures. A clinical category is a tool for organizing observations and care, while theory seeks to explain the pathways that generate them. Confusing those functions inflates certainty about causes and masks the role of culture, resources, and social context. Koenen et al. (2017) Weathers et al. (2018)
Conceptual Boundaries: Stress, Traumatic Exposure, Adaptation, and Disorder
Stress denotes a family of processes involving perceived or actual environmental demands, biological mobilization, and psychological regulation. Traumatic exposure is a more restricted event concept in the PTSD diagnostic context. It covers specified extreme threats and injuries but does not encompass every painful, unjust, or disruptive life event. Adjustment disorder can follow circumstances such as serious interpersonal conflict, job loss, financial adversity, or illness when the relevant criteria are met. Grief relates specifically to the loss of a person with whom an important bond existed. This conceptual separation prevents diagnostic overextension and permits research on harms that are serious even when they do not satisfy PTSD exposure criteria. American Psychiatric Association (2022) World Health Organization (2024)
Following a distressing event, intrusive thoughts, autonomic arousal, sleep disruption, avoidance, sadness, or impaired concentration may appear as time-limited reactions. A disorder becomes relevant when the syndrome's symptom profile, time course, associated distress, and functional consequences meet its diagnostic requirements. Exposure is neither a sufficient causal explanation nor a reliable predictor of an individual's eventual outcome. The same event type may lead to recovery in one person, sustained threat sensitivity in another, grief in a bereaved survivor, or an adjustment presentation accompanied by depression or anxiety. Studies of risk factors show that preexisting vulnerability, post-event circumstances, and social support contribute beyond exposure classification. Brewin et al. (2000) Shalev et al. (1998)
The concept of adversity includes chronic deprivation, coercion, discrimination, relational instability, disaster, war, neglect, and repeated threats, although diagnostic systems assign different meanings to those experiences. The appropriate research question is whether a documented process explains variation in symptoms and functioning. Chronic danger may undermine predictable safety learning; repeated interpersonal victimization may distort expectations about trust; disrupted attachment environments may impair children's capacity to seek comfort. None of these process hypotheses is a diagnostic shortcut. The same contextual adversity can produce different developmental and clinical outcomes, and diagnoses may coexist. Zeanah et al. (2005) Cloitre et al. (2010)
A clinical formulation must also distinguish direct event exposure from hearing about an event, occupational exposure to disturbing details, media consumption, and non-criterion secondary stress according to the diagnostic system and individual circumstance. Socially important distress should not be erased simply because it lies outside a particular diagnostic threshold. Conversely, treating all adverse experiences as formally equivalent trauma obscures the research distinction between an exposure variable and a symptom-defined outcome. Clear operational rules improve comparative studies, diagnostic reliability, service planning, and the interpretation of prevention interventions. American Psychiatric Association (2022) VA/DoD (2023)
DSM-5-TR and ICD-11: Comparative Diagnostic Architecture
DSM-5-TR and ICD-11 share the premise that certain disorders depend on the occurrence of an identifiable stressor; they differ in organization and diagnostic detail. DSM-5-TR encompasses PTSD, acute stress disorder, adjustment disorders, reactive attachment disorder, disinhibited social engagement disorder, and prolonged grief disorder within trauma- and stressor-related diagnoses. ICD-11 places PTSD, complex PTSD, prolonged grief, adjustment, and the two childhood attachment-related disorders in disorders specifically associated with stress, while classifying acute stress reaction separately. The category labels are research conventions with practical consequences for eligibility, service delivery, surveillance, and comparative epidemiology. American Psychiatric Association (2022) World Health Organization (2024)
For PTSD, DSM-5-TR retains four major symptom clusters: intrusion, avoidance, negative alterations in cognitions and mood, and alterations in arousal and reactivity, accompanied by duration and impairment requirements. ICD-11 pursues a narrower core of three groups: re-experiencing in the present, avoidance of reminders, and persistent perception of heightened current threat. A retrospective memory of the event is not automatically equivalent to a vivid sense that it is recurring now. Differences in wording, breadth, threshold, and associated features can alter which participants are diagnosed in either system. Empirical studies should report the exact algorithms rather than converting symptom counts mechanically. American Psychiatric Association (2022) World Health Organization (2024)
ICD-11 complex PTSD requires the PTSD symptom pattern together with disturbances in self-organization, while DSM-5-TR does not establish complex PTSD as a distinct diagnosis. The latter permits a more differentiated picture through PTSD symptoms, dissociative specifiers, and comorbidity. The International Trauma Questionnaire was developed to operationalize ICD-11 PTSD and complex PTSD with self-report indicators, but questionnaire assignments require appropriate validation and clinical interpretation. Comparisons that treat a positive ITQ algorithm as interchangeable with clinician-confirmed DSM-5-TR PTSD commit a measurement error. Cloitre et al. (2018) Weathers et al. (2018)
The systems also differ in the timing and wording of bereavement diagnoses, and the conditions under which exposure to severe stress or loss becomes clinically salient. Interpretation requires careful attention to culture and developmental age, particularly when expected mourning practices, caregiver availability, and normative transitions vary. There is no defensible single numerical conversion between diagnostic prevalences from differently defined systems. Crosswalk studies need parallel assessment, adequate sampling, transparent thresholds, and direct analysis of discordant cases. American Psychiatric Association (2022) World Health Organization (2024)
Causal Inference, Research Design, and Levels of Explanation
Research on stress-related disorders combines designs that make different kinds of claims. Cross-sectional studies estimate symptom prevalence, associations, and patterns of comorbidity within a defined sampling frame. Prospective cohorts can place pre-event, peri-event, and post-event measurements in temporal order and examine predictors of later trajectories. Laboratory learning tasks experimentally manipulate contingency, threat cues, or extinction conditions, supporting narrower causal claims about those manipulations. Randomized clinical trials estimate intervention effects under particular enrollment, treatment, and follow-up conditions. Evidence should be integrated across these levels without interpreting a correlation as a proven neurobiological mechanism. Brewin et al. (2000) Shalev et al. (1998)
A research tradition centered on treatment-seeking clinical participants may overrepresent severe impairment and complicated comorbidity; studies of students or veterans can establish psychometric performance without guaranteeing that identical thresholds transfer to displaced children, older adults, refugees, or people receiving primary care. Exposure-specific cohorts may be more internally coherent but less representative of the wider distribution of trauma. Researchers must examine gender, age, social resources, racialized exposure patterns, regional violence, and access to care as potential determinants of both disorder risk and inclusion in studies. Generalizability is an empirical question about sampling rather than a property established by a large sample alone. Koenen et al. (2017) Blevins et al. (2015)
Mechanistic models should specify observable mediators and measurement schedules. If maladaptive appraisals are proposed to maintain symptoms, a test should establish whether appraisal changes precede symptom changes rather than merely covary with them. If memory fragmentation is proposed to explain intrusive images, competing accounts of retrieval, emotional salience, and dissociation should be compared with valid tasks. A biomarker can correlate with severity without proving causal necessity, diagnostic specificity, or clinical usefulness. Triangulation across behavioral reports, interviews, psychophysiology, and longitudinal assessments strengthens an explanation only where the measures genuinely converge. Ehlers & Clark (2000) Brewin et al. (1996)
Outcome evaluation should distinguish clinician-rated symptoms, self-reported distress, diagnostic remission, functional return, adverse effects, and sustained improvement. An average treatment effect does not describe every patient's response, and an improvement relative to waitlist is not the same as superiority over an active credible comparator. Evidence synthesis should inspect study quality, missing follow-up, treatment adherence, unblinded assessment, selective reporting, and researcher allegiance before translating a result into a recommendation. The 2023 VA/DoD guideline offers a structured application of evidence grading and acknowledges that clinical recommendations require integrating feasibility and patient values. VA/DoD (2023) Bisson et al. (2013)
Posttraumatic Stress Disorder: Core Symptom Systems
Posttraumatic stress disorder is best studied as an organized constellation of trauma-linked intrusions, avoidance, altered danger appraisal, and changes in mood, cognition, arousal, and functioning. Intrusions can include recurrent involuntary recollections, nightmares, and episodes accompanied by a sense of re-experiencing the event. Avoidance may target places, people, conversations, internal sensations, or memories that activate the threat representation. Heightened arousal can involve vigilant scanning, exaggerated startle, sleep disruption, concentration problems, irritability, and sustained autonomic activation. These experiences may interact within individuals yet also appear in many other conditions, so the event linkage, pattern, temporal course, and differential assessment matter. American Psychiatric Association (2022) World Health Organization (2024)
The syndrome's complexity creates a challenge for symptom-count models. Two people meeting DSM-5-TR PTSD criteria may exhibit distinct profiles, such as predominant re-experiencing and avoidance in one case and extensive dysphoria and anger in another. ICD-11's narrower symptom definition was designed partly to increase clinical simplicity, yet a shorter symptom list can omit clinically important difficulties that must be assessed as comorbidity or associated impairment. Factor-analytic disagreement across instruments and populations illustrates the limits of treating a classification's cluster structure as a settled theory of psychological causation. A diagnosis offers a common communication framework; mechanisms require their own tests. Cloitre et al. (2018) Blevins et al. (2015)
Trauma reminders often function as learned predictors of danger. Their effects can be highly context-specific: a sound, odor, bodily sensation, time of day, or interpersonal situation may elicit reactions disproportionate to present danger. Avoidance may reduce immediate distress, providing short-term negative reinforcement, while limiting opportunities to update safety expectations. Consequently, a symptom can be maintained partly by the very strategy used to manage it. This learning formulation yields testable predictions about exposure and context change, but persistent symptoms can also involve shame, moral injury, ongoing danger, grief, pain, and social exclusion. A comprehensive account integrates cognition, behavior, memory, and present conditions. Foa & Kozak (1986) Ehlers & Clark (2000)
Functional impairment anchors the clinical importance of PTSD symptoms. Sleep loss, chronic fatigue, reduced occupational participation, difficulties with caregiving, and altered intimacy can sustain distress and can remain after some core symptoms improve. Depression, substance misuse, and physical health complaints may coexist, but their temporal relationship to trauma varies. Assessment therefore requires a multiaxial narrative of exposure, safety, symptom onset, remission, comorbidity, and functioning rather than an isolated numerical symptom score. Trauma-focused care also has to distinguish genuine current threat from learned danger responses because safety planning and therapeutic exposure address different conditions. VA/DoD (2023) Koenen et al. (2017)
Acute Stress Reactions and Early Post-Event Trajectories
Acute post-event responses cover a wide range of affective, cognitive, physiological, and interpersonal changes in the days and weeks after a major incident. Intense fear, emotional numbing, hypervigilance, fragmented sleep, irritability, memory intrusions, and altered concentration may occur without predicting a persistent psychiatric syndrome. Under DSM-5-TR, acute stress disorder is considered in the early posttraumatic period and requires its specific symptom profile and duration. Under ICD-11, acute stress reaction is situated among factors influencing health status, reflecting the expectation that intense immediate responses may be transient. Researchers must indicate which concept is used, especially when early intervention trials recruit participants based on symptoms rather than a diagnosed disorder. American Psychiatric Association (2022) World Health Organization (2024)
Prospective studies contributed an essential correction to retrospective accounts: the early severity of distress is informative but not determinative. Shalev and colleagues followed recently traumatized individuals after presentation to emergency services and studied the emergence and persistence of PTSD and depression. Such cohorts place symptom measurement nearer the exposure and make it possible to distinguish early persistent burden from later onset, partial improvement, and recovery. Their generalizability depends on who reaches emergency care, whether pre-trauma functioning is measured, how follow-up attrition is handled, and how the diagnostic endpoint is defined. Shalev et al. (1998)
Early response research has direct implications for prevention. Providing physical safety, shelter, reliable information, accessible support, and follow-up respects the practical needs of survivors and the uncertainty of the clinical trajectory. Psychological first aid is a pragmatic support framework that emphasizes basic needs, calm, connectedness, and facilitated access to assistance; its adoption does not mean every component has been independently proved to prevent PTSD. The evidence also argues against imposing single-session psychological debriefing as a universal mandatory prevention measure. Preventive strategies should avoid unnecessary pathologization while identifying severe or persistent difficulties that justify structured assessment. WHO et al. (2011) NICE (2018)
Targeted early trauma-focused interventions have stronger evidence in carefully selected symptomatic groups than indiscriminate treatment of all exposed individuals. Randomized trials by Bryant and colleagues examined cognitive-behavioral treatment among participants with acute stress disorder, providing experimental tests of the hypothesis that changes to avoidance and trauma-related processing can alter later outcomes. Their results must be understood in light of the trial populations, comparison conditions, treatment dose, and the historical diagnostic definitions employed. Early care is best organized as stepped monitoring and access to appropriate evidence-based intervention rather than a universal assumption that distress predicts a lifelong condition. Bryant et al. (1998) Bryant et al. (2008)
Complex Posttraumatic Stress Disorder and Disturbances in Self-Organization
ICD-11 complex posttraumatic stress disorder integrates the core PTSD profile with disturbances in self-organization. The additional domains concern problems regulating affect, a persistently negative sense of self, and enduring difficulties in maintaining or experiencing relationships. These domains are clinically meaningful because chronic interpersonal threat may affect how a person interprets their own worth, anticipates others' responses, and regulates strong emotion in ordinary situations. Complex PTSD may be associated with repeated or prolonged trauma from which escape is difficult, but exposure to any specific event type is not an automatic diagnosis. Symptoms and impairment determine whether criteria are met. World Health Organization (2024) Cloitre et al. (2018)
The category raises an important conceptual issue: a group of symptoms can be statistically distinguishable without being produced by an entirely independent causal mechanism. Negative self-concept and relational insecurity overlap with depression, personality pathology, attachment insecurity, and chronic stress. A useful classification must demonstrate additional clinical validity, meaningful prediction of course or treatment response, and reliability across cultural and developmental groups. The ITQ provides a brief measure of ICD-11 symptoms and disturbances in self-organization, but its thresholds and factor structure should be tested in each population. Diagnosis requires integrating these reports with a full clinical assessment. Cloitre et al. (2018) VA/DoD (2023)
Theoretical accounts emphasize chronic threat-related learning, disturbances in autobiographical and interpersonal meaning, emotion regulation burdens, and limited opportunities for adaptive safety experiences. They are compatible with heterogeneous pathways rather than a single required sequence from childhood abuse to complex PTSD. Experiences of shame, betrayal, disconnection, and chronic perceived danger may sustain symptoms, while supportive relationships and changed environments can facilitate recovery. Trauma research must distinguish the historical exposure profile from mechanisms that are observable and modifiable in the present. A person can experience extensive developmental adversity and still show neither PTSD nor complex PTSD. Ehlers & Clark (2000) Cloitre et al. (2010)
Intervention studies are informative but do not establish a one-size-fits-all requirement for lengthy preliminary stabilization. Cloitre and colleagues examined a skills-oriented intervention followed by exposure for participants with PTSD related to childhood abuse, testing the value of emotion and interpersonal skills within a structured treatment sequence. Other evidence supports effective trauma-focused approaches across heterogeneous presentations. The relevant research agenda compares phase-based and immediately trauma-focused regimens in adequately powered randomized designs while recording adverse events, dropout, functioning, patient preference, and complex PTSD-specific outcomes. Clinical adaptations are justified by individual needs and evidence rather than a presumed uniform severity hierarchy. Cloitre et al. (2010) VA/DoD (2023)
Adjustment Disorder and the Organization of Stressor-Linked Distress
Adjustment disorder examines clinically important distress and disruption following identifiable psychosocial stressors that may fall within ordinary life experience. Common contexts include relationship dissolution, relocation, unemployment, academic transitions, illness, caregiving burdens, or major social losses. The diagnostic problem is to identify a response that is sufficiently persistent and impairing to merit clinical attention while recognizing contextual variations in what constitutes expected adaptation. ICD-11 emphasizes preoccupation with the stressor or its consequences and failure to adapt; DSM-5-TR applies its own timing and distress or impairment formulation. Neither system licenses inference from the existence of a stressor alone. World Health Organization (2024) American Psychiatric Association (2022)
Adjustment disorder has historically been difficult to measure because stressors are heterogeneous, symptoms overlap with depressive and anxiety disorders, and the boundaries between expected grief, understandable distress, and clinically significant impairment can be uncertain. Development and validation of measures explicitly linked to ICD-11 offer a way to examine the defined symptom pattern instead of relying on an impressionistic residual label. Such instruments require testing for discriminant validity, stability, responsiveness, and culturally appropriate interpretation. The presence of depressive symptoms does not automatically imply major depressive disorder, just as the absence of trauma-specific re-experiencing does not exclude a meaningful stress-related impairment. Kazlauskas et al. (2018) World Health Organization (2024)
The central mechanisms proposed for adjustment problems include repeated cognitive engagement with a stressor, threat or loss appraisal, difficulties with problem solving, disrupted routines, diminished social resources, and attempts to avoid reminders of unsolved circumstances. These processes interact with actual external constraints: an individual cannot cognitively reappraise away poverty, an unsafe workplace, or the practical demands of chronic illness. Therefore psychological models should distinguish modifiable interpretations and coping behavior from structural determinants that require social, legal, medical, or material response. Research on adjustment must treat the stressor as an ongoing variable rather than a static historical event. Kazlauskas et al. (2018) Brewin et al. (2000)
Evidence for specific treatments is less extensive and more heterogeneous than the PTSD psychotherapy literature, partly because of variable definitions and outcome measures. Studies should separate spontaneous improvement from intervention effects, use credible comparison conditions, and examine occupational participation, relationships, and sustained functioning. Shared decision making about the person's goals, the continuing stressor, and available support is integral to a research-informed formulation. A rigorous account leaves open whether some observed treatment benefits reflect disorder-specific mechanisms or general improvements in social support, sleep, coping, and structured problem resolution. VA/DoD (2023) World Health Organization (2024)
Prolonged Grief Disorder and Bereavement-Specific Processes
Grief is a human response to the death of an important person and can encompass yearning, sadness, anger, disbelief, changes in identity, and recurrent contact with memories of the deceased. The scientific question concerns when a grief response becomes persistently and substantially disruptive and whether the symptom organization warrants a specific diagnosis. ICD-11 recognizes prolonged grief disorder with core persistent longing or preoccupation and accompanying emotional pain and impairment after a culturally contextualized period following death. DSM-5-TR also recognizes prolonged grief disorder, with its own duration thresholds and symptom rules. Researchers must preserve these exact diagnostic definitions rather than treating ordinary bereavement, prolonged grief disorder, and depression as interchangeable constructs. World Health Organization (2024) American Psychiatric Association (2022)
Traumatic bereavement can involve simultaneous grief and threat-related symptoms, especially when death occurred through violence, sudden disaster, or conflict. Persistent yearning for the deceased differs phenomenologically from reliving a traumatic threat, although both can generate intrusive experiences, avoidance, and distress. Major depression often involves pervasive low mood and anhedonia across contexts, whereas grief may retain a distinctive relational focus; nevertheless, substantial overlap and comorbidity occur. Differential assessment asks what is being avoided, what is anticipated, how the relationship to the deceased is experienced, what functioning has changed, and how cultural mourning conventions shape the symptoms. Simon & Shear (2024) Shear et al. (2005)
Randomized treatment research established that grief-focused psychotherapy can improve outcomes among carefully defined participants. In a 2005 trial, Shear and colleagues randomly assigned 95 adults with complicated grief to a specialized intervention or interpersonal psychotherapy and reported a larger response proportion in the targeted treatment group. A later placebo-controlled factorial trial among 395 bereaved adults evaluated complicated grief treatment with or without citalopram, permitting assessment of psychotherapy and medication contributions within the enrolled population. These findings are evidence for specific protocols and historical trial case definitions; they do not imply that every bereaved person needs clinical treatment or that the contemporary DSM-5-TR category precisely matches all previous complicated-grief criteria. Shear et al. (2005) Shear et al. (2016)
Persistent grief must be interpreted within the structure of a person's bonds, cultural obligations, changes in community roles, and the conditions under which remembrance is possible. Measurement tools need to consider culturally patterned expressions of loss and the time elapsed since bereavement. The field still faces questions about diagnostic thresholds, the functional role of continuing bonds, treatment access across settings, and how best to assess bereaved children or displaced populations. A defensible clinical approach recognizes legitimate variation in mourning while identifying individuals with sustained impairment who may benefit from targeted intervention. Simon & Shear (2024) World Health Organization (2024)
Childhood Attachment Disorders and Severe Caregiving Adversity
Reactive attachment disorder and disinhibited social engagement disorder concern early developmental disturbances associated with a history of grossly insufficient care. Their placement within stressor-related classifications emphasizes the critical role of caregiving conditions in the formation of selective relationships and social approach. Reactive attachment disorder involves markedly reduced seeking or responding to comfort in the context of inadequate caregiving, whereas disinhibited social engagement disorder involves developmentally inappropriate familiarity and reduced reticence with unfamiliar adults. These patterns should not be used as informal labels for any insecure attachment style, social anxiety, or difficult behavior. They require a detailed developmental and caregiving history. American Psychiatric Association (2022) World Health Organization (2024)
Studies of institutional deprivation, including research with children raised in Romanian institutions, offered unusually important observations of how early caregiving environments relate to attachment behavior, indiscriminate social approach, and socioemotional development. Zeanah and colleagues compared attachment organization in institutionalized and community children, illustrating that early deprivation may be associated with measurable variation in relational behavior. Such findings support the developmental importance of consistent caregiving while leaving questions about genetic, prenatal, placement, and broader contextual contributions. Quasi-experimental and longitudinal designs require attention to selection and the child's opportunities for later recovery. Zeanah et al. (2005)
The distinction between attachment organization and an attachment-related disorder is foundational. Secure, insecure, and disorganized attachment classifications arise from particular observational paradigms and concern relationship patterns; they are not diagnostic synonyms for reactive attachment disorder or disinhibited social engagement disorder. Children with autism, developmental delays, depressive symptoms, or histories of multiple placements may show superficially similar social behavior for different reasons. Assessment must consider developmental age, the child's opportunities to form selective attachments, the reliability of caregiving reports, and possible co-occurring neurodevelopmental or psychiatric conditions. Zeanah et al. (2005) American Psychiatric Association (2022)
Research and clinical interpretation in this domain carry special ethical responsibilities. Intervention should prioritize safe, responsive, stable caregiving environments, developmentally appropriate relationship support, and evidence-informed services. Practices that use coercion, restraint, or humiliation under a supposed attachment-repair rationale cannot be justified by the classification itself. Because children's access to care depends on family systems, adoption and placement policies, and social service resources, their outcomes require cross-sector longitudinal research. A diagnosis should direct attention to the child's developmental needs and circumstances rather than assign blame through an overgeneralized theory of attachment damage. World Health Organization (2024) Zeanah et al. (2005)
Threat Learning, Avoidance, and the Persistence of Fear
Associative learning offers one experimentally tractable level of explanation for persistent posttraumatic symptoms. A previously neutral cue may acquire threat significance by appearing in proximity to danger, and later produce defensive responses even when the original danger is absent. Instrumental avoidance can then reduce short-term anxiety, reinforcing behaviors that prevent new encounters with safe circumstances. In daily life, these learned patterns may extend to places, social encounters, bodily sensations, and thoughts associated with the original event. The general formulation predicts that sustained avoidance can interfere with safety learning, while the precise causal role of avoidance in clinical PTSD requires longitudinal and experimental tests. Foa & Kozak (1986) Ehlers & Clark (2000)
Foa and Kozak's emotional-processing account proposed that pathological fear involves representations linking stimulus information, responses, and meanings, and that correction requires encounter with information incompatible with the feared expectations. Exposure-based interventions draw on this tradition by facilitating engagement with trauma memories or safe reminders under structured clinical conditions. This model is scientifically productive because it specifies conditions under which threat expectations should change. At the same time, laboratory extinction and clinical exposure are not identical processes: treatment outcomes reflect motivation, meaning, alliance, context, and numerous mechanisms that are difficult to isolate. Foa & Kozak (1986) Foa et al. (1991)
Extinction learning does not necessarily erase an initial association; new inhibitory learning may remain sensitive to context, spontaneous recovery, and renewed threat. This observation helps explain why change acquired in a therapy room may not transfer immediately to every everyday setting. The clinical implication is a research question about generalization, not a license to intensify exposure without regard to safety or tolerability. A person's current environment may still contain genuine threats, and the ethical priority is to distinguish those dangers from conditioned expectations in circumstances that are sufficiently safe for learning. Foa & Kozak (1986) VA/DoD (2023)
Fear conditioning alone leaves important dimensions unexplained. Persistent guilt and shame can maintain social withdrawal through moral evaluations and identity beliefs; anger may reflect both defensive readiness and perceived injustice; grief can concern irretrievable relational loss; dissociation can alter the person's access to cues and emotional states. Models that treat all PTSD symptoms as fear alone will underrepresent these presentations. A broader mechanism map connects associative learning with appraisal, memory, affect regulation, interpersonal context, and ongoing stress. The empirical challenge is to identify which component drives impairment in a given case and which changes follow successful treatment. Ehlers & Clark (2000) Brewin et al. (1996)
Trauma Memory, Intrusive Re-experiencing, and Autobiographical Meaning
Intrusive trauma memories are often sensory, emotionally intense, and difficult to control, but their phenomenology varies. A sensory fragment accompanied by a sense of present danger differs from a voluntary autobiographical account that locates the event clearly in the past. Dual representation theory, developed by Brewin, Dalgleish, and Joseph, proposed distinct but interacting forms of trauma representation to explain this dissociation between involuntary images and contextualized recollection. The theory was influential in directing research toward memory organization and retrieval, but its proposed representational architecture should be treated as a model whose specific claims need experimental support. Brewin et al. (1996)
Ehlers and Clark's cognitive model links persistent PTSD to a sense of serious current threat arising from maladaptive appraisals and features of trauma memory. A person may interpret a normal reminder as evidence of imminent danger, or a distressing reaction as proof of permanent damage. Repeated attempts at suppression, checking, rumination, and avoidance can preserve those appraisals and prevent corrective experience. This account links cognitive content with maintaining behaviors and generates treatment targets such as reappraisal, memory elaboration, and behavioral experiments. Its mechanistic claims are distinct from the fact that cognitive therapy can be effective in an outcome trial. Ehlers & Clark (2000) VA/DoD (2023)
The claim that traumatic memories are invariably fragmented, repressed, or inaccessible is too strong. Autobiographical memory is reconstructive, emotionally salient material can be vivid yet inaccurate in detail, and both voluntary and involuntary retrieval can occur. The relationship between dissociation, subjective memory disorganization, and objective memory performance depends on definition and measurement. Researchers should separate an individual's experienced discontinuity in recall from experimentally demonstrated encoding deficits. Interview questions, repeated retelling, suggestion, and subsequent information can all influence later reports, requiring careful ethical procedures in clinical and forensic settings. Brewin et al. (1996) Weathers et al. (2018)
Trauma narratives also organize self-interpretation and social meaning. A traumatic experience may be integrated into an evolving life story, linked to beliefs about agency and safety, or repeatedly revisited in attempts to understand responsibility. These processes are shaped by interpersonal recognition, legal contexts, stigma, and the availability of listeners who respond credibly. Research on memory and meaning is strongest when the same individual is followed across time and multiple evidence types are collected. One should not infer the exact occurrence, sequence, or causal details of an event solely from the emotional intensity of a memory report. Ehlers & Clark (2000) Foa & Kozak (1986)
Psychobiology of Stress and the Limits of Biomarkers
Acute threat recruits coordinated autonomic, neuroendocrine, and behavioral responses, including changes in attention, heart rate, vigilance, and readiness for action. The hypothalamic–pituitary–adrenal axis and sympathetic systems are often discussed in accounts of posttraumatic stress, while networks involved in salience, contextual memory, and emotion regulation offer candidate neural pathways. These are interacting physiological processes with major individual and temporal variation. The presence of an altered group mean in one physiological variable does not establish a disease-specific biological signature suitable for individual diagnosis. Shalev et al. (1998) VA/DoD (2023)
Prospective research attempted to determine whether early autonomic activation predicts later clinical outcomes. Shalev and colleagues reported associations between early posttraumatic responses and subsequent symptoms in emergency-care cohorts. Even when a predictor precedes the outcome, it may index severity, pain, sleep deprivation, medication exposure, prior vulnerability, or ongoing adversity rather than a unique causal pathway. Prediction research requires external validation and assessment of whether the variable improves classification above simpler clinical and social information. A statistically significant physiological association is insufficient to justify routine biomarker-based screening. Shalev et al. (1998)
Neuroimaging studies of PTSD frequently examine networks involving amygdala-centered threat processing, medial prefrontal regulation, hippocampal contextual memory, and broad functional connectivity. However, diverse tasks, sample characteristics, comorbidities, analytic pipelines, and medication histories limit anatomical claims. Similar regions participate in normal threat learning and numerous psychiatric states. Mechanistic progress depends on repeated measurement, preregistered predictions, transparent analysis, and designs that relate circuit-level changes to behavioral learning and clinically meaningful outcomes. Such evidence may eventually improve patient stratification, but a brain image is not a diagnostic substitute for a structured clinical assessment. VA/DoD (2023) Weathers et al. (2018)
The relationship between mental symptoms and the body is reciprocal over time. Persistent nightmares and insomnia can amplify daytime vigilance, while musculoskeletal pain, gastrointestinal symptoms, concussion sequelae, or chronic illness can alter symptom descriptions and recovery. Some physiological responses may be consequences of ongoing distress, others moderators of it, and still others shared effects of an exposure or a third variable. The scientific task is to distinguish these possibilities through temporal and intervention designs, not to choose a single biological story before the evidence is measured. VA/DoD (2023) Brewin et al. (2000)
Risk, Resilience, Epidemiology, and Heterogeneous Trajectories
Exposure to extreme events is common relative to the proportion of people who develop a sustained PTSD diagnosis. A World Mental Health Surveys analysis by Koenen and colleagues drew on cross-national data and demonstrated that prevalence depends upon the population denominator, trauma exposure, event type, and diagnostic operationalization. The investigation included 26 surveys across multiple countries and reported a lifetime PTSD prevalence of 3.9 percent in the full sampled population and 5.6 percent among trauma-exposed respondents. Those figures describe the study's specified sampling and assessment framework; they should not be transformed into a universal 2026 prevalence estimate or extrapolated to current war-affected communities. Koenen et al. (2017)
Meta-analysis of adult PTSD risk factors identified contributions from prior psychological difficulty, previous trauma, peri-event reactions, and post-event social circumstances. Effects varied across factors and studies, emphasizing that risk unfolds through time. Exposure characteristics alone are insufficient: loss of home, ongoing insecurity, social exclusion, unstable income, discrimination, legal uncertainty, and difficulties obtaining care can influence later symptom burden. A model that considers only individual personality or neurobiology neglects factors that may be both powerful and modifiable at the level of community and policy. Brewin et al. (2000) Koenen et al. (2017)
Resilience should be defined as a trajectory or set of adaptive processes rather than a fixed personality label. Some survivors sustain stable functioning despite exposure, some experience temporary disruption followed by recovery, some show persistent symptoms, and others have delayed or fluctuating difficulties. The shape of these trajectories can be distorted by sparse follow-up, retrospective reconstruction, attrition, and the assumption that a few measurement occasions represent a continuous course. Repeated prospective assessments and interpretable clinical endpoints are necessary to determine whether apparently distinct trajectory classes reflect substantive differences or model artifacts. Shalev et al. (1998) Koenen et al. (2017)
Social support is a recurring correlate of posttraumatic outcomes, but associations can reflect several causal directions. Support may reduce practical burden and foster safety; severe symptoms may also make relationships difficult and alter received support. Studies should distinguish anticipated support, actually available assistance, social integration, and the quality of interpersonal responses to disclosure. Population risk is also distributed unequally because opportunities for exposure and access to recovery resources differ. An epidemiology of stressor-related disorders therefore examines social determinants together with individual mechanisms, preserving attention to both structural prevention and clinical treatment. Brewin et al. (2000) Koenen et al. (2017)
Structured Interviews and Psychometric Assessment
Clinical assessment begins by identifying the relevant event or stressor, establishing the chronology of symptoms, and evaluating distress, impairment, safety, and competing explanations. A structured interview can improve the consistency with which a clinician elicits symptom frequency, intensity, functional relevance, and exposure criteria. The Clinician-Administered PTSD Scale for DSM-5, or CAPS-5, was developed as a structured diagnostic and severity measure; the Posttraumatic Stress Disorder Checklist for DSM-5, or PCL-5, is a self-report questionnaire reflecting DSM-5 symptom content. These instruments answer related but different assessment questions and should not be treated as equivalent diagnostic gold standards. Weathers et al. (2018) Blevins et al. (2015)
Initial PCL-5 psychometric work reported strong internal consistency and convergent validity in trauma-exposed student samples. In the first study of 278 participants, the authors reported internal consistency of alpha .94 and a test–retest coefficient of .82; a second study examined 558 participants. These results support use of the instrument for measuring symptom severity in studied contexts but do not prove diagnostic interchangeability across languages, age groups, or clinical populations. A threshold derived from one reference population can perform differently when the prevalence, symptom distribution, or costs of false positives differ. Instrument research therefore needs calibration, validity and reliability evidence at the point of intended use. Blevins et al. (2015)
The CAPS-5 offers symptom-anchored clinician assessment and permits evaluation of diagnostic criteria and severity, while the PCL-5 can facilitate screening or repeated symptom tracking. The ITQ uses a different diagnostic framework to assess ICD-11 PTSD and complex PTSD. Differences among these instruments are substantive: each assumes a particular construct definition and method of observation. Evaluating one against another requires a reference procedure appropriate to the relevant diagnosis. Psychiatric interviews should also document dissociative presentations, psychotic symptoms, substance effects, concussion, medical conditions, sleep disorders, and the effects of ongoing exposure when these might change the formulation. Weathers et al. (2018) Cloitre et al. (2018) VA/DoD (2023)
Psychometric quality encompasses more than internal consistency. Test–retest reliability, inter-rater agreement, measurement invariance, sensitivity to change, interpretability of scores, and correspondence with functioning all affect scientific usefulness. A questionnaire may have a coherent factor structure and still miss important experiences among people unfamiliar with its cultural idiom. Translation and adaptation must assess meaning and not merely lexical equivalence. Intensive longitudinal measures can capture within-person fluctuations missed by a one-month recall instrument, but their burdens, missing responses, and context-dependent reactivity create a different set of measurement problems. Blevins et al. (2015) Cloitre et al. (2018)
Complex PTSD, Adjustment, and Grief Measurement
The International Trauma Questionnaire was developed by Cloitre and collaborators to operationalize the narrower ICD-11 PTSD symptoms and additional complex PTSD disturbances in self-organization. Its brevity makes it useful for research across settings, but a brief instrument does not remove the need to verify the qualifying exposure, symptom meaning, impairment, and relevant differential diagnoses. A comparison of PTSD and complex PTSD prevalence based on the ITQ should state the validated scoring algorithm, version, language, sampling frame, and whether clinical confirmation occurred. When the same sample is measured by another diagnostic framework, discordance may reveal genuine classification differences rather than an instrument failure. Cloitre et al. (2018) World Health Organization (2024)
Adjustment disorder measurement requires particular care because the stressor itself may be ongoing and different categories of stressor may produce similar symptom reports. Kazlauskas and colleagues investigated a brief measure oriented toward ICD-11 adjustment disorder, contributing to the operationalization of preoccupation and failure to adapt. Validity studies must show that these dimensions add information beyond general distress and that symptoms are related temporally and functionally to an identifiable stressor. Assessment should consider the person's circumstances, culture, and feasible opportunities to change the stressor, rather than treating a high score as a self-sufficient explanation of inability to adapt. Kazlauskas et al. (2018) World Health Organization (2024)
Prolonged grief instruments face a related definitional challenge. Trials historically recruited participants using complicated-grief constructs that partly precede contemporary ICD-11 and DSM-5-TR criteria. Therefore longitudinal comparisons and evidence syntheses must report which measure, threshold, time since bereavement, and cultural qualification was applied. Treatment response reported on one complicated-grief scale cannot be assumed to establish remission under every current diagnostic algorithm. Research should preserve the difference between a loss-specific symptom dimension, a clinically assessed disorder, and a general depressive mood score. Shear et al. (2005) Shear et al. (2016) Simon & Shear (2024)
Assessment quality ultimately depends on the coherence of the clinical inference. Exposure history, symptom report, behavioral evidence, collateral information when appropriate, developmental history, and functional consequences should converge into a formulation that can be revised when new information appears. Where the data are ambiguous, researchers should describe that ambiguity as a substantive feature of classification. The goal is accurate measurement and meaningful prediction, including evaluation of whether intervention reduces suffering and restores valued functioning. Diagnostic certainty should never be manufactured by stacking highly correlated questionnaires that ask largely the same questions. Weathers et al. (2018) VA/DoD (2023)
Differential Diagnosis, Comorbidity, and Clinical Formulation
PTSD commonly overlaps in presentation with depressive disorders, anxiety conditions, substance use problems, dissociative symptoms, sleep disturbance, and chronic pain. Intrusive thoughts may arise in obsessive-compulsive disorder, but their meaning and relation to a qualifying traumatic event may differ. Panic attacks can occur in PTSD or as a feature of panic disorder; hypervigilance can reflect current danger, generalized worry, trauma reminders, or a medical condition. A diagnosis should be evaluated from its required structure rather than from one dramatic symptom. The possibility of co-occurring disorders remains open when more than one complete criterion set is met. American Psychiatric Association (2022) VA/DoD (2023)
Complex PTSD and some personality-related difficulties may overlap in emotion regulation, self-concept, and interpersonal functioning. The diagnostic analysis should examine the entire developmental and symptom pattern, stable versus state-dependent difficulties, the role of trauma-related threat, and the evidence supporting the relevant classification. False dichotomies are especially unhelpful when chronic adversity and personality processes may have reciprocal relationships. Similarly, sustained grief may coexist with major depression or PTSD following a violent death, without being reducible to either category. The clinician needs to identify which symptoms have independent clinical significance and which treatment targets have supporting evidence. World Health Organization (2024) Simon & Shear (2024)
Substance use can function as an attempt to manage nightmares, distress, withdrawal from painful memories, or insomnia, while intoxication and withdrawal can themselves contribute to autonomic arousal, mood changes, and disrupted sleep. Treatment studies that exclude severe comorbidity may not represent patients facing several simultaneous problems. Differential assessment requires a careful temporal history of alcohol and other drug use, trauma symptoms, medication exposure, and social contexts. A structured, collaborative formulation can address safety and symptom burden alongside substance use without assuming that one problem must universally be cured before the other can be treated. VA/DoD (2023) Koenen et al. (2017)
Medical and neurological conditions must be assessed when clinically relevant, particularly concussion, traumatic brain injury, seizure disorders, medication effects, chronic pain, and sleep-related disorders. Changes in concentration, memory, irritability, and arousal have broad differential explanations. The presence of a traumatic event does not license retrospective attribution of every subsequent symptom to PTSD. The strongest formulations identify what is known from direct clinical evidence, what remains a plausible hypothesis, and which observations would change the diagnosis or treatment plan. Clinical evaluation also includes risk assessment, current environmental safety, and the patient's goals. VA/DoD (2023) Weathers et al. (2018)
Developmental Course in Children and Adolescents
The expression of traumatic stress changes with cognitive development, language, dependence on caregivers, and the organization of childhood memory. Younger children may communicate distress through play themes, sleep disturbance, separation difficulties, behavioral regression, or changes in social engagement rather than detailed verbal narratives. Adolescents may show avoidance, aggression, dissociation, concentration problems, and altered self-understanding, while also navigating peer relationships and emerging autonomy. Diagnostic rules and screening measures therefore require developmentally sensitive interpretation. Identical adult-style questions cannot be assumed to measure the same construct in a preschool child. American Psychiatric Association (2022) NICE (2018)
Adverse experiences in childhood often occur within relationships on which a child depends. Threat may be intertwined with caregiving, housing instability, school disruption, and community violence. A developmental formulation must distinguish direct traumatization, exposure to loss, disrupted attachment opportunity, and ordinary age-related changes. Caregiver support can shape both recovery conditions and accuracy of symptom reporting, although caregiver and child accounts may disagree for understandable reasons. Assessment should protect children from suggestive questioning and attend to their immediate physical and relational safety. Zeanah et al. (2005) WHO et al. (2011)
Experimental treatment evidence supports trauma-focused cognitive-behavioral approaches for many children and adolescents with clinically important posttraumatic symptoms. A multisite randomized trial by Cohen and colleagues compared trauma-focused cognitive-behavioral therapy with a child-centered approach among sexually abused children and evaluated trauma-related symptoms and associated outcomes. An individual participant data meta-analysis published in 2024 integrated information from 25 randomized studies comprising 1,686 children and adolescents to examine trauma-focused CBT efficacy and moderators. The stronger methodological features of participant-level synthesis coexist with limitations: only five contributing studies were rated at low risk of bias, while twenty had some concerns. Cohen et al. (2004) de Haan et al. (2024)
Developmental research also addresses treatment adaptations, parental involvement, culture, displacement, and access barriers. A treatment designed for children with caregiver support may require changes when a caregiver is the perpetrator, when housing is unstable, or when family participation would create risk. Trials should report school attendance, social functioning, safety, retention, and clinically meaningful long-term outcomes rather than relying only on symptom differences immediately after intervention. Children's protection, agency, privacy, and developmental needs belong inside the causal and ethical structure of clinical research. de Haan et al. (2024) NICE (2018)
Culture, Displacement, Collective Violence, and Social Conditions
Stress-related disorders are investigated across societies in which exposure, language, cultural accounts of distress, mental-health systems, and social resources differ substantially. Cross-national studies establish that severe events and PTSD symptoms occur in diverse contexts, yet observed prevalence reflects both exposure patterns and diagnostic measurement. People displaced by war or disaster may face prolonged uncertainty, separation, poverty, interrupted health care, and recurring exposure; the post-event environment can therefore become a continuing source of risk rather than a recovery setting. Research needs to distinguish the effect of the initial event from the effects of subsequent displacement and social instability. Koenen et al. (2017) Brewin et al. (2000)
Culture shapes which reactions are regarded as ordinary mourning, how fear and bodily distress are described, what sources of support are trusted, and whether a clinical explanation is socially acceptable. This does not imply that severe symptoms exist only as cultural constructions; it means their observation and interpretation depend on language, practice, and local institutions. Cross-cultural assessment requires translation, construct validation, appropriate reference periods, and sensitivity to social meaning. An adapted questionnaire should be checked for differential item functioning instead of assuming that a shared numeric scale guarantees shared psychological meaning. World Health Organization (2024) Cloitre et al. (2018)
War-related research must also address sustained danger and structural disruption. A person living under repeated air attacks or ongoing violence may display vigilance that is appropriate to real conditions, and interventions that rely on exposure to supposed safety require a credible assessment of actual risk. Ethical support includes access to shelter, trustworthy information, medical care, legal protections, and community resources alongside specialized psychological services. The availability of those resources can influence whether clinical improvement is sustained. Prevention thus requires both individual services and the conditions that make recovery possible. WHO et al. (2011) VA/DoD (2023)
Remote and digital interventions can expand access when transport, stigma, cost, or geographical displacement obstruct care. At the same time, digital access, privacy, internet stability, language, and safe therapeutic setting vary. The 2023 VA/DoD guideline supports secure video delivery of evidence-based PTSD psychotherapy in circumstances where it has been validated and suitable. Research should evaluate whether outcomes replicate across cultures and resource conditions, measure attrition and harms, and distinguish access improvements from equivalence of clinical effects in every population. VA/DoD (2023) NICE (2018)
Trauma-Focused Psychotherapies: Experimental Foundations
Psychotherapy research provides an unusually extensive body of controlled evidence for adult PTSD compared with many other stressor-related conditions. The most studied trauma-focused approaches include prolonged exposure, cognitive processing therapy, and eye movement desensitization and reprocessing. These protocols differ in their procedures and theoretical vocabulary but commonly address persistent trauma-linked meanings, memories, and avoidance within a structured therapeutic relationship. The 2023 VA/DoD guideline strongly recommends these three manualized treatments and recommends them over medication as a treatment class for PTSD. The clinical implication is a hierarchy of evidence supporting shared decision making, not a claim that every individual responds identically. VA/DoD (2023) Bisson et al. (2013)
Early exposure trials tested whether structured engagement with traumatic memories and avoided reminders would reduce symptoms relative to control procedures. Foa and colleagues' 1991 randomized study involving rape survivors compared cognitive-behavioral procedures with counseling, contributing to an experimental basis for exposure-oriented care. Subsequent studies across different populations investigated therapist-guided exposure, cognitive restructuring, and combinations of methods. Their internal validity depends on randomization, assessor masking, credible comparators, fidelity, and complete follow-up. Generalization to people facing current violence, severe comorbidity, language barriers, or ongoing unsafe conditions requires additional investigation. Foa et al. (1991) Schnurr et al. (2007)
Cognitive processing therapy emphasizes examination of trauma-related beliefs concerning safety, trust, power, esteem, intimacy, and responsibility. Research among military veterans and civilian populations investigates whether systematic cognitive work can reduce PTSD severity and improve functioning. A randomized trial by Monson and colleagues evaluated cognitive processing therapy for military-related PTSD, adding a separate experimental tradition to exposure-focused studies. The existence of multiple effective modalities makes comparative effectiveness, accessibility, tolerability, and patient preference important scientific questions. Mechanism research should test whether changes in beliefs and emotion precede symptom improvement rather than presuming the answer from the therapy's stated rationale. Monson et al. (2006) Ehlers & Clark (2000)
EMDR incorporates trauma memory processing with bilateral stimulation procedures and a structured treatment protocol. Its evidence base must be separated into two questions: whether the full intervention produces clinically meaningful benefit, and which components are responsible for that benefit. Shapiro's early work helped establish the intervention as a research subject; later guideline evaluations assess whole-protocol outcomes from subsequent trials and syntheses. A recommendation for EMDR as a treatment is not direct proof that a particular proposed neurophysiological mechanism explains its effects. Component research and carefully designed dismantling studies remain important. Shapiro (1989) VA/DoD (2023)
Comparative Treatment Effectiveness and Evidence Quality
Clinical trial interpretation depends heavily on comparator selection. A treatment compared with waitlist tests more than the specific mechanism of the intervention: therapist contact, expectation, monitoring, structured activity, and the passage of time may all contribute. Trials with an active credible alternative provide a stronger test of specific advantages but often show smaller between-group differences. A 2007 multisite randomized study by Schnurr and colleagues examined prolonged exposure versus present-centered therapy among women veterans and active-duty personnel, adding evidence from a population that had been less prominent in early combat-focused literature. Treatment allocation, outcome assessment, treatment completion, and follow-up need to be considered together. Schnurr et al. (2007)
Systematic reviews by Bisson and collaborators synthesized psychotherapy trials for chronic PTSD, providing an overview of the evidence available at the time of the review. Such work is indispensable for judging whether apparently compelling individual trials reflect an overall pattern. However, a review's conclusions are bounded by its search date, eligibility criteria, intervention grouping, risk-of-bias assessment, and the distribution of study settings. The evidence base continues to change through new trials, alternative delivery modes, and methodological reassessments. The present dossier uses published reviews as evidence sources and does not reproduce their search or pooled calculations. Bisson et al. (2013) VA/DoD (2023)
Clinical improvement should be tracked with more than a questionnaire total. Reduction in re-experiencing, avoidance, nightmares, and arousal matters, but so do work and school participation, social connectedness, physical functioning, safety, and the ability to pursue personally meaningful goals. Remission from diagnostic criteria can occur with residual distress, while substantial improvement can occur without complete threshold remission. Studies with prolonged follow-up are particularly important because the immediate post-treatment difference may not describe later relapse or maintenance. Patient-reported burden, clinician-rated outcomes, and adverse events should each be measured with appropriate methods. Weathers et al. (2018) VA/DoD (2023)
Evidence limitations include selective enrollment, treatment allegiance, attrition, inconsistent adverse-event reporting, site differences, and insufficient representation of severe co-occurring conditions. Trauma-focused care can temporarily increase distress during difficult material; this possibility calls for collaborative planning, risk monitoring, and empirical assessment rather than assuming harm or safety without evidence. Real-world implementation studies should examine therapist competence, patient choice, cost, wait times, cultural adaptation, and reach. The strongest treatment claim is tied to a well-defined population, intervention, comparator, and outcome, with uncertainty made visible where trials are sparse. Bisson et al. (2013) VA/DoD (2023)
Pharmacotherapy, Sleep, and Regulatory Evidence
Medication evidence for PTSD includes trials of selective serotonin reuptake inhibitors and a serotonin–norepinephrine reuptake inhibitor, as well as investigations of sleep-related and adjunctive treatments. The 2023 VA/DoD guideline supports paroxetine, sertraline, or venlafaxine when pharmacotherapy is selected for PTSD, while giving priority to established trauma-focused psychotherapies where feasible and acceptable. A pharmacological intervention may reduce symptoms for some individuals without directly resolving the memories, interpersonal burdens, or environmental stressors that contribute to the condition. Drug selection and monitoring require clinical evaluation of comorbidity, tolerability, contraindications, interactions, and patient preferences. VA/DoD (2023)
Regulatory status should be specified separately from an evidence-based clinical recommendation. In the United States, sertraline and paroxetine have FDA-labeled indications for PTSD, while venlafaxine is commonly discussed in PTSD guidance despite a different formal indication status. A drug's approval for depression or anxiety does not automatically mean it is approved for PTSD. Because product labeling can change, the current prescribing information must be checked when any specific indication, warning, pregnancy exposure, or dosing issue is discussed. This dossier does not supply individual dosing regimens and treats medication as a research and clinical-guideline topic. VA/DoD (2023)
Nightmares, insomnia, and fragmented sleep can maintain daytime distress and are meaningful treatment outcomes in their own right. The 2023 VA/DoD guidance distinguishes prazosin considerations for trauma-related nightmares from its limited support as a treatment of PTSD overall. That distinction illustrates the difference between symptom-specific benefit and improvement of the entire syndrome. Behavioral treatment of insomnia, nightmare-focused interventions, sleep hygiene in its appropriate context, and assessment of sleep apnea or substance effects may also be clinically relevant. Comparative trials must avoid extrapolating improvement in one sleep outcome to broad diagnostic remission. VA/DoD (2023)
The same clinical guideline recommends against benzodiazepines for PTSD and against cannabis or cannabis-derived products for PTSD treatment, based on its evidence and safety assessments. Such recommendations are not judgments about every possible indication for a medication; they concern PTSD under the guideline's question and evidence framework. Research should distinguish a regulatory authorization, a demonstrated treatment effect, off-label clinical practice, and a theoretical pharmacological mechanism. When evidence is uncertain or experimental, that status belongs in the scientific presentation. Medication-related research cannot be translated into individualized prescriptions by a reference encyclopedia. VA/DoD (2023)
Targeted Treatment of Prolonged Grief and Adjustment Difficulties
Prolonged grief research yielded disorder-focused psychotherapies designed to address painful separation, avoidance of reminders of the death, and difficulties reengaging in meaningful life activity. The randomized work by Shear and colleagues compared specialized complicated grief treatment with interpersonal psychotherapy and found greater treatment response in the specialized intervention among recruited participants. The trial supports the causal effect of a specific package within its defined population, while its historical diagnostic criteria differ from some current formulations. Research should explicitly map the intervention's targets to persistent yearning, relational meaning, functional change, and the person's goals. Shear et al. (2005) Simon & Shear (2024)
A later large randomized clinical trial studied complicated grief treatment in combination with citalopram or placebo and compared psychotherapy and medication conditions. The findings provide evidence on the value of targeted psychotherapy and the limits of assuming that antidepressant response alone resolves grief-specific symptoms. Comorbid depression can nevertheless require its own assessment and treatment. The scientific distinction is between intervention effects on grief symptoms, depressive symptoms, and functioning, with each outcome measured and reported separately. This is particularly important when studies enroll individuals who meet historical complicated grief criteria rather than exactly the current DSM-5-TR or ICD-11 rules. Shear et al. (2016) American Psychiatric Association (2022)
Adjustment disorder intervention research remains a more heterogeneous domain. Supportive counseling, structured problem solving, stress-management techniques, brief cognitive-behavioral approaches, and practical social assistance have plausible relevance, but a plausible mechanism is not sufficient evidence of comparative efficacy. Stressors such as unemployment or displacement involve structural obstacles that psychotherapy alone may leave unchanged. A research program should evaluate outcomes under active comparator conditions and measure the continuing external demands. The intervention's ethical aim is to increase functioning and reduce distress without portraying the person's environment as irrelevant. World Health Organization (2024) Kazlauskas et al. (2018)
Interventions for child attachment-related disturbances focus principally on the quality, continuity, safety, and responsiveness of caregiving and associated developmental services. These objectives reflect the developmental conditions in which the disorders arise. Treating the child as the isolated target of an individual symptom procedure is inadequate when relational deprivation or instability continues. Research requires longitudinal evaluation of placement conditions, attachment behavior, developmental functioning, and harms from unsuitable practices. Intervention labels should be scrutinized carefully because claims of attachment repair vary greatly in theoretical credibility and clinical safety. Zeanah et al. (2005) World Health Organization (2024)
Prevention, Implementation, and Trauma-Informed Systems
Prevention can be understood at three linked levels: reducing exposure to violence and severe adversity, supporting people soon after an incident, and preventing persistent impairment among those developing symptoms. Each level has a different outcome and evidential basis. Structural measures involving safety, emergency response, housing, equitable access to care, and child protection are not interchangeable with individual clinical protocols. Psychological first aid organizes humane immediate assistance around safety, practical needs, information, and connection to support. It is a framework for early response rather than a proven universal PTSD-prevention treatment. WHO et al. (2011) VA/DoD (2023)
Targeted screening and follow-up are useful when a person is significantly distressed, functioning poorly, or at increased risk, but their design should preserve the high probability of improvement among many exposed individuals. The early-stage work by Bryant and colleagues illustrates how trauma-focused interventions can be tested among carefully characterized symptomatic survivors. Screening programs must evaluate false positive results, whether an effective follow-up service exists, and the risk of turning expected reactions into unnecessarily medicalized identities. An ethical program measures outcomes beyond the act of screening, including whether participants actually receive and benefit from support. Bryant et al. (1998) Bryant et al. (2008)
Implementation research examines why highly supported treatments may remain inaccessible. Barriers can include workforce training, cost, geographic separation, unsafe housing, stigma, language, limited appointment capacity, and a mismatch between available therapy and patient priorities. Telehealth may address some barriers, but privacy, digital exclusion, continuity, and clinician competence remain relevant. Systems should facilitate informed choice among evidence-supported options and monitor meaningful results rather than equating treatment initiation with successful care. The VA/DoD guideline explicitly integrates evidence strength with feasibility and patient preferences. VA/DoD (2023) NICE (2018)
A trauma-informed organization recognizes that prior exposure can shape expectations about power, bodily autonomy, safety, and trust during interactions with institutions. In health, education, legal, and humanitarian settings, this may motivate transparent communication, predictable procedures, consent, and attention to potentially distressing practices. Yet the label trauma-informed is not itself an empirical effectiveness claim. Its constituent changes must be evaluated against specified outcomes, including safety, engagement, patient experience, symptom change, and equity. Institutional response is part of the research object because service environments can either reduce or reproduce threatening conditions. WHO et al. (2011) VA/DoD (2023)
Critical Discussion: Evidence Strength Across the Diagnostic Grouping
The evidence base is uneven across trauma- and stressor-related diagnoses. Adult PTSD has a substantial tradition of operationalized symptom measurement and randomized psychotherapy trials, with additional support from meta-analyses and graded clinical guidelines. Complex PTSD has increasingly explicit criteria and measurement tools, but important uncertainty remains about diagnostic separability, treatment matching, and generalization beyond studied samples. Prolonged grief has a growing body of targeted psychotherapy trials conducted under partly evolving diagnostic definitions. Adjustment disorder and childhood attachment-related diagnoses present distinct challenges of threshold validity, limited controlled treatment evidence, and contextual dependence. The correct conclusion is diagnosis-specific, rather than a blanket verdict on the grouping. Bisson et al. (2013) Cloitre et al. (2018) Shear et al. (2016) World Health Organization (2024)
Classification is strongest when its categories predict clinically meaningful differences in prognosis, intervention need, or service utilization beyond the symptom measures that defined them. The same symptom might be placed under PTSD, a depressive condition, an adjustment response, or a mixed formulation depending on duration, exposure, meaning, and the accompanying pattern. Differences between ICD-11 and DSM-5-TR offer a valuable natural comparison for evaluating clinical utility but also complicate estimates of epidemiological burden. Agreement between instruments may be high without establishing a singular biological entity. Reliable clinical categories remain useful while their constructs are continually tested. American Psychiatric Association (2022) World Health Organization (2024) Weathers et al. (2018)
Evidence hierarchies have to remain sensitive to the research question. Randomized trials are often the most direct evidence about the effect of an intervention, but they may not describe rare harms, social determinants, or long-term developmental trajectories. Prospective observational studies establish time order and identify potential predictors, yet they require adjustment for confounding and selection. Psychometric studies clarify what a scale measures, not whether a therapy works. Qualitative investigations can reveal meanings and mechanisms omitted by fixed instruments, though their transferability is assessed differently. Combining these sources improves explanation only when the evidential role of each is respected. Shalev et al. (1998) Blevins et al. (2015) VA/DoD (2023)
Clinical practice guidelines provide an interpreted summary of research under a specified scope and review date. The 2023 VA/DoD PTSD guideline uses a transparent framework of clinical questions and graded recommendations; NICE guidance likewise addresses PTSD treatment pathways in particular health-system conditions. A guideline's strength is that it systematically evaluates many studies and considers implementation, but it is not an original experiment and does not settle every question about mechanisms or underserved populations. This monograph treats recommendations as reported positions of the issuing bodies, preserves treatment-context distinctions, and does not claim that a bibliographic narrative review constitutes an independent clinical practice guideline. VA/DoD (2023) NICE (2018)
Unresolved Questions and the Next Research Agenda
One central question concerns diagnostic validity across systems. Researchers need longitudinal cohorts assessed simultaneously under DSM-5-TR and ICD-11, with external outcomes that include impairment, treatment response, service needs, and patient-defined recovery. Such work can establish where two labels identify overlapping clinical presentations and where differences improve prediction. Special attention should be given to complex PTSD and its disturbances in self-organization, the relation between prolonged grief and depression, the boundary between adjustment disorder and expected adversity-related distress, and the distinctions between attachment-related disorders and other developmental difficulties. World Health Organization (2024) Cloitre et al. (2018) Simon & Shear (2024)
Mechanism research needs stronger connections among experimental learning, within-person symptom dynamics, autobiographical memory, interpersonal context, and prospective change. Threat-conditioning findings should be evaluated against naturalistic data about ongoing safety, while cognitive models must specify which appraisals change first and predict subsequent improvement. Neurobiological candidates require independent replication and demonstration of incremental predictive utility. Because symptom patterns are heterogeneous, multilevel designs may identify different maintaining processes rather than one universal pathology. Models should state measurable predictions before being applied to individual patients. Foa & Kozak (1986) Ehlers & Clark (2000) Shalev et al. (1998)
Intervention questions include comparative effectiveness of trauma-focused modalities, long-term durability, how best to support severe comorbidity, the role of phase-based approaches for complex PTSD, accessible care for displaced populations, and the balance of therapist-led and digital delivery. Many studies need better monitoring of adverse events, inclusion of vulnerable groups, active comparators, and assessment of functioning over long intervals. For children, future research should include developmental changes, caregiver safety, educational outcomes, and whether early improvements persist. Participant-level evidence synthesis can evaluate moderators more effectively than isolated small trials but still depends on the quality and representativeness of contributing studies. VA/DoD (2023) de Haan et al. (2024) Cloitre et al. (2010)
Public-health research faces a related set of questions: how to reduce exposure before harm occurs; how to provide effective help while violence or deprivation continues; and how to assess inequities in care without converting collective suffering into individual pathology. Administrative prevalence figures must state their definitions and denominators. Interdisciplinary studies should connect disaster response, housing, social support, child protection, and legal institutions with repeated psychological outcomes. Ethical research entails informed consent, safe handling of trauma narratives, data minimization, culturally informed measurement, and protocols for responding to acute risk encountered during assessment. WHO et al. (2011) Koenen et al. (2017)
Interdisciplinary Integration and the Artificial Era
Contemporary trauma research takes place in information environments where survivors encounter digital reminders, remote services, automated communication, and algorithmically mediated access to resources. These environments are relevant insofar as they alter measurable processes such as memory cue exposure, threat appraisal, social support, sleep, privacy, and availability of clinical care. A digital platform can amplify repeated exposure to disturbing material, facilitate mutual aid, or enable remote evidence-based treatment, depending on design and use. The causal claim must be attached to observable variables and study design; the mere presence of an artificial system is not an established risk or protective factor. VA/DoD (2023) WHO et al. (2011)
Human–Artificial Relations provide an emerging research context for examining how people interpret guidance, support, and authority in digitally mediated interactions. In the Artificial Era, new forms of assistance may change the distribution of emotional labor, information-seeking, language access, and continuity of support. For stressor-related disorders, useful research questions concern whether automated tools preserve privacy, accurately identify when human clinical involvement is necessary, reinforce avoidance or catastrophizing, and improve rather than displace access to qualified care. These questions require prospective evaluation, safety monitoring, and clear operational definitions. No evidence presented here permits attributing clinical competence or treatment efficacy to a system on the basis of its conversational fluency. VA/DoD (2023)
Research involving artificial systems should distinguish psychological effects on human users from claims about the internal state of the systems. A clinical trial may evaluate changes in human symptoms after using a digital intervention without resolving philosophical questions about machine understanding. The Artificial Era framework offers a historical and interdisciplinary horizon for studying new relations among people, institutions, and artificial technologies. Its scientific value for this dossier lies in the formulation of measurable hypotheses about treatment access, mediated disclosure, trust, data governance, and repeated trauma reminders. Philosophical claims and empirical conclusions remain separately attributable. WHO et al. (2011) VA/DoD (2023)
Future studies can compare guided digital interventions with ordinary services using randomized designs, examine the fidelity of automated referrals to human professionals, and evaluate whether repeated digital prompts change avoidance or symptom monitoring. Privacy breaches and inappropriate reassurance are foreseeable harms to assess, not automatically demonstrated outcomes. Investigators should include exposure to continuing threat, cultural suitability, accessibility, diagnostic heterogeneity, and the ethics of obtaining consent when developing tools for survivors. Long-term scientific progress depends on showing exactly what an artificial or hybrid service does, whom it benefits, and where qualified clinical judgment remains necessary. VA/DoD (2023) NICE (2018)
Research Synthesis: A Multilevel Model of Stressor-Dependent Clinical Change
The strongest synthesis begins with the distinction between exposure and clinical outcome. A stressor creates conditions of risk, but symptoms emerge through processes of learning, appraisal, memory, affect regulation, development, and social context. These processes change over time and interact with the availability of safety, material resources, interpersonal support, and treatment. The same event can initiate different pathways, and similar symptoms can arise from different exposures and diagnoses. Accordingly, a scientific account describes the event, the resulting symptom configuration, the time course, the functional impact, and the evidence for proposed mechanisms as separate though connected levels. Brewin et al. (2000) Koenen et al. (2017)
At the explanatory level, threat-related learning provides a mechanism for cue-triggered fear and avoidance, cognitive appraisals describe meanings that sustain present threat, autobiographical memory models address the form and retrieval of intrusions, and developmental accounts examine the role of caregiving and prolonged adversity. The explanatory reach of each model is limited by its object. Grief-specific processes center on a consequential attachment loss and the reorganization of life after death, while adjustment disorder depends on a broader identifiable stressor and adaptation burden. Different models may complement each other within a patient or diverge in empirically testable predictions. Foa & Kozak (1986) Ehlers & Clark (2000) Brewin et al. (1996) Simon & Shear (2024)
At the measurement level, a diagnosis is a decision based on operational requirements, while scales describe particular dimensions and interviews establish a fuller clinical picture. DSM-5-TR and ICD-11 offer partly different but systematically comparable descriptions. Validity assessment must be population-specific; a high self-report score is evidence about reported symptoms and may prompt further evaluation, but should not be confused with a completed diagnosis. Longitudinal data are needed to distinguish temporary distress, recovery, persistence, and deterioration. The same logic applies to treatment outcomes, where reduced severity, improved functioning, and sustained safety should be evaluated distinctly. American Psychiatric Association (2022) World Health Organization (2024) Blevins et al. (2015)
At the intervention level, the largest and most interpretable treatment evidence applies to specified PTSD psychotherapies and to targeted grief psychotherapy in defined samples. Other interventions have narrower or more heterogeneous evidence. Clinical guidance must therefore preserve the diagnosis, population, outcome, and strength of the recommendation. Prevention requires both assistance with acute human needs and access to specialized care when clinically indicated. The result is a scientific framework in which psychological symptoms are situated within relationships, institutions, developmental time, and changing environments, and the confidence of each conclusion follows its evidence. VA/DoD (2023) Bisson et al. (2013) Shear et al. (2016)
Research Developments in 2025–2026: Construct Validity and Comparative Outcomes
A 2025 individual participant data meta-analysis by Wright and colleagues assessed trauma-focused cognitive-behavioral therapies in randomized adult PTSD trials. It brought together comparisons against inactive and active interventions while analyzing individual-level outcomes. Across the included evidence, the trauma-focused treatments were more effective than inactive comparison conditions, whereas the analysis did not find a statistically significant symptom-severity advantage over active comparison conditions. This distinction is central to comparative effectiveness: superiority to no active intervention supports treatment benefit, while failure to demonstrate superiority over an active alternative leaves the relative merits of effective therapies dependent on treatment characteristics, outcome definitions, and precision. Wright et al. (2025)
In 2026, Kindred and colleagues published a meta-analytic confirmatory factor analysis of the International Trauma Questionnaire, synthesizing 57 studies and data from 43,066 participants. The two higher-order factor model corresponding to ICD-11 PTSD and disturbances in self-organization showed acceptable fit; however, a seven-factor correlated first-order structure fitted the item relationships better across assessed subgroups. The authors also identified limited internal consistency for some brief subscales. The result is a challenge to the view that a useful diagnostic framework necessarily entails a single best-fitting psychometric structure. It argues for continued item refinement, independent clinical validation, and precision in using brief symptom scales. Kindred et al. (2026)
Direct trials of complex PTSD interventions also test claims about necessary treatment sequencing. Sele and collaborators randomized 92 adults with PTSD and ICD-11 complex PTSD after childhood abuse to a phase-based STAIR Narrative Therapy program, prolonged exposure, or skills training. The 2023 trial did not support the hypothesis that the phase-based program was superior to the alternatives; changes across PTSD and disturbances-in-self-organization outcomes differed by treatment and assessment point. The authors explicitly emphasized the need for further investigation. This finding limits any blanket recommendation that every person with complex PTSD must first complete a particular stabilization phase before trauma-focused care. Sele et al. (2023)
The 2026 randomized evaluation of psychotherapy addressing the impact of killing during war provides a contemporary example of a narrower treatment target within trauma-related clinical populations. Its sample comprised veterans with PTSD and moral injury who had previously tried evidence-based PTSD treatment, and its comparator was present-centered therapy. The observed benefits establish a research signal for the specialized protocol within that enrolled group, while replication, independent transportability, and mechanistic clarification remain important. Together, these recent studies show that clinical innovation, psychometric critique, and more demanding treatment comparisons can coexist. Scientific advancement consists partly in narrowing claims to the populations and outcomes actually studied. Maguen et al. (2026) Kindred et al. (2026) Wright et al. (2025)
Conclusion
Trauma- and stressor-related disorders constitute a family of research objects united by the diagnostic significance of identifiable stressful events and differentiated by their symptom systems, exposure requirements, developmental conditions, and course. PTSD focuses on persistent trauma-linked threat and memory symptoms; ICD-11 complex PTSD adds disturbances in self-organization; adjustment disorder concerns impairing adaptation to a broader range of stressors; prolonged grief disorder concerns enduring, functionally disruptive bereavement-specific suffering; and early childhood attachment-related disorders are linked to severe insufficiency of care. Acute reactions require careful interpretation within the relevant classification and time frame. The diagnostic systems provide structured definitions for scientific inquiry and clinical practice. World Health Organization (2024) American Psychiatric Association (2022)
The empirical record establishes heterogeneous trajectories after severe events and identifies important contributions from prior vulnerability, learning, appraisals, memory, social circumstances, and opportunities for recovery. Standardized interviews, validated self-report instruments, prospective cohorts, randomized intervention trials, and evidence synthesis each contribute different knowledge. The strength of inference depends on explicit operational definitions, appropriate comparison conditions, longitudinal observation, cultural validation, and transparent acknowledgment of uncertainty. Population estimates and treatment results remain tied to their original samples and methods. Koenen et al. (2017) Blevins et al. (2015) Shalev et al. (1998)
Evidence-based trauma-focused psychotherapy has substantial support for adult PTSD, and child-focused trauma treatment and specialized grief therapy have meaningful research foundations. The evidence for other stressor-related conditions differs in scope, quality, and relevance to specific interventions. A rigorous scientific and clinical interpretation integrates current safety, contextual needs, personal values, potential comorbidity, and measured functional outcomes. Continued research should clarify diagnostic boundaries, individual trajectories, mechanism-specific treatment response, long-term outcomes, and the conditions under which social and digitally mediated services improve recovery. These priorities establish trauma-related psychopathology as a multilevel science of exposure, adaptation, relationships, and change. VA/DoD (2023) de Haan et al. (2024) Shear et al. (2016)
References
- American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Association Publishing. https://doi.org/10.1176/appi.books.9780890425787
- Bisson, J. I., Roberts, N. P., Andrew, M., Cooper, R., & Lewis, C. (2013). Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews, 2013(12), CD003388. https://doi.org/10.1002/14651858.CD003388.pub4
- Blevins, C. A., Weathers, F. W., Davis, M. T., Witte, T. K., & Domino, J. L. (2015). The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation. Journal of Traumatic Stress, 28(6), 489–498. https://doi.org/10.1002/jts.22059
- Brewin, C. R., Dalgleish, T., & Joseph, S. (1996). A dual representation theory of posttraumatic stress disorder. Psychological Review, 103(4), 670–686. https://doi.org/10.1037/0033-295X.103.4.670
- Brewin, C. R., Andrews, B., & Valentine, J. D. (2000). Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. Journal of Consulting and Clinical Psychology, 68(5), 748–766. https://doi.org/10.1037/0022-006X.68.5.748
- Bryant, R. A., Harvey, A. G., Dang, S. T., Sackville, T., & Basten, C. (1998). Treatment of acute stress disorder: A comparison of cognitive-behavioral therapy and supportive counseling. Journal of Consulting and Clinical Psychology, 66(5), 862–866. https://doi.org/10.1037/0022-006X.66.5.862
- Bryant, R. A., Mastrodomenico, J., Felmingham, K. L., Hopwood, S., Kenny, L., Kandris, E., Cahill, C., & Creamer, M. (2008). Treatment of acute stress disorder: A randomized controlled trial. Archives of General Psychiatry, 65(6), 659–667. https://doi.org/10.1001/archpsyc.65.6.659
- Cloitre, M., Shevlin, M., Brewin, C. R., Bisson, J. I., Roberts, N. P., Maercker, A., Karatzias, T., & Hyland, P. (2018). The International Trauma Questionnaire: Development of a self-report measure of ICD-11 PTSD and complex PTSD. Acta Psychiatrica Scandinavica, 138(6), 536–546. https://doi.org/10.1111/acps.12956
- Cloitre, M., Stovall-McClough, K. C., Nooner, K., Zorbas, P., Cherry, S., Jackson, C. L., Gan, W., & Petkova, E. (2010). Treatment for PTSD related to childhood abuse: A randomized controlled trial. American Journal of Psychiatry, 167(8), 915–924. https://doi.org/10.1176/appi.ajp.2010.09081247
- Cohen, J. A., Deblinger, E., Mannarino, A. P., & Steer, R. A. (2004). A multisite, randomized controlled trial for children with sexual abuse-related PTSD symptoms. Journal of the American Academy of Child & Adolescent Psychiatry, 43(4), 393–402. https://doi.org/10.1097/00004583-200404000-00005
- de Haan, A., Meiser-Stedman, R., Landolt, M. A., Kuhn, I., Black, M. J., Klaus, K., Patel, S. D., Fisher, D. J., Haag, C., Ukoumunne, O. C., Jones, B. G., Flaiyah, A. M., Catani, C., Dawson, K., Bryant, R. A., de Roos, C., Ertl, V., Foa, E. B., Ford, J. D., … Dalgleish, T. (2024). Efficacy and moderators of efficacy of cognitive behavioural therapies with a trauma focus in children and adolescents: An individual participant data meta-analysis of randomised trials. The Lancet Child & Adolescent Health, 8(1), 28–39. https://doi.org/10.1016/S2352-4642(23)00253-5
- Ehlers, A., & Clark, D. M. (2000). A cognitive model of posttraumatic stress disorder. Behaviour Research and Therapy, 38(4), 319–345. https://doi.org/10.1016/S0005-7967(99)00123-0
- Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99(1), 20–35. https://doi.org/10.1037/0033-2909.99.1.20
- Foa, E. B., Rothbaum, B. O., Riggs, D. S., & Murdock, T. B. (1991). Treatment of posttraumatic stress disorder in rape victims: A comparison between cognitive-behavioral procedures and counseling. Journal of Consulting and Clinical Psychology, 59(5), 715–723. https://doi.org/10.1037/0022-006X.59.5.715
- Kazlauskas, E., Gegieckaite, G., Eimontas, J., Zelviene, P., & Maercker, A. (2018). A brief measure of the International Classification of Diseases-11 adjustment disorder: Investigation of psychometric properties in an adult help-seeking sample. Psychopathology, 51(1), 10–15. https://doi.org/10.1159/000484415
- Kindred, R., Jak, S., Hamer, R., Nedeljkovic, M., & Bates, G. W. (2026). Evaluating the ICD-11 PTSD and complex PTSD constructs: A meta-analytic confirmatory factor analysis of the International Trauma Questionnaire. Assessment, 33(4), 510–532. https://doi.org/10.1177/10731911251340837
- Koenen, K. C., Ratanatharathorn, A., Ng, L., McLaughlin, K. A., Bromet, E. J., Stein, D. J., Karam, E. G., Ruscio, A. M., Benjet, C., Scott, K., Atwoli, L., Petukhova, M., Lim, C. C. W., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Bunting, B., Ciutan, M., de Girolamo, G., … Kessler, R. C. (2017). Posttraumatic stress disorder in the World Mental Health Surveys. Psychological Medicine, 47(13), 2260–2274. https://doi.org/10.1017/S0033291717000708
- Maguen, S., Gloria, R., Lehrner, A., Beckham, J. C., Wells, S. Y., Pratchett, L., Davis, J., Barnes, D. E., & Burkman, K. (2026). Psychotherapy for impact of killing during war: A randomized clinical trial. JAMA Psychiatry. Advance online publication. https://doi.org/10.1001/jamapsychiatry.2026.2307
- Monson, C. M., Schnurr, P. P., Resick, P. A., Friedman, M. J., Young-Xu, Y., & Stevens, S. P. (2006). Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. Journal of Consulting and Clinical Psychology, 74(5), 898–907. https://doi.org/10.1037/0022-006X.74.5.898
- National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE guideline NG116). https://www.nice.org.uk/guidance/ng116
- Schnurr, P. P., Friedman, M. J., Engel, C. C., Foa, E. B., Shea, M. T., Chow, B. K., Resick, P. A., Thurston, V., Orsillo, S. M., Haug, R., Turner, C., & Bernardy, N. (2007). Cognitive behavioral therapy for posttraumatic stress disorder in women: A randomized controlled trial. JAMA, 297(8), 820–830. https://doi.org/10.1001/jama.297.8.820
- Sele, P., Hoffart, A., Cloitre, M., Hembree, E., & Øktedalen, T. (2023). Comparing phase-based treatment, prolonged exposure, and skills-training for complex posttraumatic stress disorder: A randomized controlled trial. Journal of Anxiety Disorders, 100, 102786. https://doi.org/10.1016/j.janxdis.2023.102786
- Shalev, A. Y., Freedman, S., Peri, T., Brandes, D., Sahar, T., Orr, S. P., & Pitman, R. K. (1998). Prospective study of posttraumatic stress disorder and depression following trauma. American Journal of Psychiatry, 155(5), 630–637. https://doi.org/10.1176/ajp.155.5.630
- Shapiro, F. (1989). Eye movement desensitization: A new treatment for post-traumatic stress disorder. Journal of Behavior Therapy and Experimental Psychiatry, 20(3), 211–217. https://doi.org/10.1016/0005-7916(89)90025-6
- Shear, K., Frank, E., Houck, P. R., & Reynolds, C. F., III. (2005). Treatment of complicated grief: A randomized controlled trial. JAMA, 293(21), 2601–2608. https://doi.org/10.1001/jama.293.21.2601
- Shear, M. K., Reynolds, C. F., III, Simon, N. M., Zisook, S., Wang, Y., Mauro, C., Duan, N., Lebowitz, B., & Skritskaya, N. (2016). Optimizing treatment of complicated grief: A randomized clinical trial. JAMA Psychiatry, 73(7), 685–694. https://doi.org/10.1001/jamapsychiatry.2016.0892
- Simon, N. M., & Shear, M. K. (2024). Prolonged grief disorder. New England Journal of Medicine, 391(13), 1227–1236. https://doi.org/10.1056/NEJMcp2308707
- U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for management of posttraumatic stress disorder and acute stress disorder (Version 4.0). https://www.healthquality.va.gov/guidelines/MH/ptsd/
- Weathers, F. W., Bovin, M. J., Lee, D. J., Sloan, D. M., Schnurr, P. P., Kaloupek, D. G., Keane, T. M., & Marx, B. P. (2018). The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychological Assessment, 30(3), 383–395. https://doi.org/10.1037/pas0000486
- World Health Organization, War Trauma Foundation, & World Vision International. (2011). Psychological first aid: Guide for field workers. World Health Organization. https://www.who.int/publications/i/item/9789241548205
- World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. World Health Organization. https://www.who.int/publications/b/68103
- Wright, S. L., Karyotaki, E., Sijbrandij, M., Cuijpers, P., Bisson, J. I., Papola, D., Witteveen, A. B., Back, S. E., Bichescu-Burian, D., Capezzani, L., Cloitre, M., Devilly, G. J., Elbert, T., Mello, M. F., Ford, J. D., Grasso, D., Gray, R., Haller, M., Hunt, N., … Seedat, S. (2025). Efficacy of cognitive behavioral therapies with a trauma focus for posttraumatic stress disorder: An individual participant data meta-analysis. Journal of Consulting and Clinical Psychology, 93(6), 401–426. https://doi.org/10.1037/ccp0000942
- Zeanah, C. H., Smyke, A. T., Koga, S. F., Carlson, E., & Bucharest Early Intervention Project Core Group. (2005). Attachment in institutionalized and community children in Romania. Child Development, 76(5), 1015–1028. https://doi.org/10.1111/j.1467-8624.2005.00894.x